Pacific Biosciences of California Inc
NASDAQ:PACB
| Market Cap (Intraday) | 4.73B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $27.71 |
| 50-Day MA | $29.65 |
| 200-Day MA | $30.70 |
Pacific Biosciences of California Inc Stock, NASDAQ:PACB
1305 O'Brien Drive, Menlo Park, California 94025
United States of America
Phone: +1.650.521.8000
Number of Employees: 412
Description
Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. The firm's products and services include PacBio sequel system, consumables, analytical software and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.